AAAAAA

   
Results: 1-8 |
Results: 8
Delayed hypersensitivity skin testing to mumps and Candida albicans antigens is normal in middle-aged HTLV-I- and -II-Infected U.S. cohorts
Authors: Murphy, EL Wu, Y Ownby, HE Smith, JW Ruedy, RK Thomson, RA Ameti, DI Wright, DJ Nemo, GJ
Citation: El. Murphy et al., Delayed hypersensitivity skin testing to mumps and Candida albicans antigens is normal in middle-aged HTLV-I- and -II-Infected U.S. cohorts, AIDS RES H, 17(13), 2001, pp. 1273-1277
Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease
Authors: Murphy, EL Collier, AC Kalish, LA Assmann, SF Para, MF Flanigan, TP Kumar, PN Mintz, L Wallach, FR Nemo, GJ
Citation: El. Murphy et al., Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease, ANN INT MED, 135(1), 2001, pp. 17-26
Risk factors for hepatitis C virus infection in United States blood donors
Authors: Murphy, EL Bryzman, SM Glynn, SA Ameti, DI Thomson, RA Williams, AE Nass, CC Ownby, HE Schreiber, GB Kong, FH Neal, KR Nemo, GJ
Citation: El. Murphy et al., Risk factors for hepatitis C virus infection in United States blood donors, HEPATOLOGY, 31(3), 2000, pp. 756-762
Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulinin HIV type 1-infected children (Pediatric AIDS Clinical Trials Group Protocol 273)
Authors: Stiehm, ER Fletcher, CV Mofenson, LM Palumbo, PE Kang, MH Fenton, T Sapan, CV Meyer, WA Shearer, WT Hawkins, E Fowler, MG Bouquin, P Purdue, L Sloand, EM Nemo, GJ Wara, D Bryson, YJ Starr, SE Petru, A Burchett, S
Citation: Er. Stiehm et al., Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulinin HIV type 1-infected children (Pediatric AIDS Clinical Trials Group Protocol 273), J INFEC DIS, 181(2), 2000, pp. 548-554
Absence of human T-lymphotropic virus type I tax sequences in a populationof normal blood donors in the Baltimore, MD/Washington, DC, area: results from a multicenter study
Authors: Cowan, EP Nemo, GJ Williams, AE Alexander, RK Vallejo, A Hewlett, IK Lal, RB Dezzutti, CS Gallahan, D George, K Pancake, BA Zucker-Franklin, D McCurdy, PR Tabor, E
Citation: Ep. Cowan et al., Absence of human T-lymphotropic virus type I tax sequences in a populationof normal blood donors in the Baltimore, MD/Washington, DC, area: results from a multicenter study, TRANSFUSION, 39(8), 1999, pp. 904-909
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
Authors: Mofenson, LM Lambert, JS Stiehm, ER Bethel, J Meyer, WA Whitehouse, J Moye, J Reichelderfer, P Harris, DR Fowler, MG Mathieson, BJ Nemo, GJ
Citation: Lm. Mofenson et al., Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine, N ENG J MED, 341(6), 1999, pp. 385-393
Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: Results of pediatric AIDS clinical trials group protocol 185
Authors: Stiehm, ER Lambert, JS Mofenson, LM Bethel, J Whitehouse, J Nugent, R Moye, J Fowler, MG Mathieson, BJ Reichelderfer, P Nemo, GJ Korelitz, J Meyer, WA Sapan, CV Jimenez, E Gandia, J Scott, G O'Sullivan, MJ Kovacs, A Stek, A Shearer, WT Hammill, H
Citation: Er. Stiehm et al., Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: Results of pediatric AIDS clinical trials group protocol 185, J INFEC DIS, 179(3), 1999, pp. 567-575
Increased incidence of infectious diseases during prospective follow-up ofhuman T-lymphotropic virus type II- and I-infected blood donors
Authors: Murphy, EL Glynn, SA Fridey, J Smith, JW Sacher, RA Nass, CC Ownby, HE Wright, DJ Nemo, GJ
Citation: El. Murphy et al., Increased incidence of infectious diseases during prospective follow-up ofhuman T-lymphotropic virus type II- and I-infected blood donors, ARCH IN MED, 159(13), 1999, pp. 1485-1491
Risultati: 1-8 |